Candida albicans, Cryptococcus neoformans or Aspergillus fumigatus induces an antifungal activity in mouse serum,

Ken-Ichi OKAZAKI1, Masahiro ASAKURA, Norihiko SUGIMOTO

  • 1Graduate School of Life and Environmental Sciences, Osaka Prefecture University, Izumisano, Osaka, Japan.

Insights

Mouse serum exhibits antifungal activity against fungi like Candida albicans, Cryptococcus neoformans, and Aspergillus fumigatus. This activity is not due to transferrin but likely other serum proteins limiting iron availability for fungal growth.

Area of Science:

  • Immunology
  • Mycology
  • Biochemistry

Background:

  • Antifungal activity in mouse serum following Candida albicans administration was previously attributed to transferrin.
  • The role of serum proteins in inhibiting fungal growth requires further elucidation.

Purpose of the Study:

  • To investigate the antifungal activity induced by various fungi in mouse serum.
  • To determine the specific serum component responsible for this observed antifungal effect.

Main Methods:

  • Induction of antifungal activity in mouse serum by Candida albicans, Cryptococcus neoformans, and Aspergillus fumigatus.
  • In vitro growth inhibition assays using RPMI1640 medium with and without transferrin, fetal bovine serum (FBS), or treated mouse serum.
  • Assessment of ferrous ion's effect on antifungal activity.

Main Results:

  • Fungal challenge with C. albicans, C. neoformans, or A. fumigatus induced antifungal activity in mouse serum.
  • Antifungal activity was inhibited by ferrous ion, suggesting iron limitation.
  • Transferrin inhibited fungal growth in vitro, but this effect was abolished by FBS.
  • Treated mouse serum, but not FBS, inhibited fungal growth, indicating the presence of other active components.

Conclusions:

  • The antifungal activity induced by C. albicans, C. neoformans, and A. fumigatus in mouse serum is likely mediated by unknown serum proteins, not transferrin.
  • These unknown proteins appear to restrict iron availability, thereby inhibiting fungal growth.

Related Concept Videos

Antifungal Agents01:15

Antifungal Agents

Amphotericin B is a broad-spectrum antifungal agent that exploits structural differences between fungal and mammalian cell membranes. Its amphipathic structure—featuring a hydrophobic polyene-lactone ring and a hydrophilic region containing mycosamine and carboxylic acid groups—enables selective binding to ergosterol, a sterol predominantly found in fungal plasma membranes. This selective interaction underlies the drug’s antifungal activity, although weak binding to cholesterol contributes to...
Cryptococcal Meningitis01:27

Cryptococcal Meningitis

Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
Candidiasis01:20

Candidiasis

Candidiasis is a fungal infection caused by opportunistic species of Candida. It can affect various anatomical sites, including the skin, oral cavity, nails, and genitourinary tract. Among its forms, vaginal candidiasis is the most common type of mucosal infection. It typically results from the overgrowth of Candida albicans in the vaginal mucosa. Under normal conditions, C. albicans exists as a commensal organism within the vaginal microbiota, regulated by the dominance of lactobacilli, which...